EPI-001, a compound active against castration-resistant prostate cancer, targets transactivation unit 5 of the androgen receptor

Castration-resistant prostate cancer is the lethal condition suffered by prostate cancer patients that become refractory to androgen deprivation therapy. EPI-001 is a recently identified compound active against this condition that modulates the activity of the androgen receptor, a nuclear receptor t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:ACS Chem Biol
Autori principali: De Mol, Eva, Fenwick, R. Bryn, Phang, Christopher T. W., Buzón, Victor, Szulc, Elzbieta, de la Fuente, Alex, Escobedo, Albert, García, Jesús, Bertoncini, Carlos W., Estébanez-Perpiñá, Eva, McEwan, Iain J., Riera, Antoni, Salvatella, Xavier
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5027137/
https://ncbi.nlm.nih.gov/pubmed/27356095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschembio.6b00182
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi